3/ Culture. "I still don’t think that the prospect of being sexually assaulted was as bad as watching the next generation of sexual harassers being formed. I think that was the worst part for me." (Nontenure-track faculty) #MeToo#MeTooSTEM#womeinmedicine#MedEd#heforshe
2/Although CMS requires Part D formularies to include OUD treatment, and mandate Part C Medicare Advantage to cover behav health services related to addiction services, the only FDA approved OAT meeting the Part D definition is bupe/naloxone
3/Further, if bupe/naloxone is administered in an OTP it will not be reimbursed, because an OTP is not a pharmacy, a reimbursement requirement for Part D. Same issue for methadone. Methadone is required to be OTP administered (42 CFR 8.12) it is not a qualified Part D product.
2/ Title IX. This article is missing information about federally mandated reporting processes and protections that legally protect medical students (and all students in the U.S.).
3/Anecdotal beliefs perpetuate harms. A physician expert states “the trainee must amass allies before lodging this complaint…” This is legally incorrect, a single report is enough to trigger Title IX and this reinforces the notion that single reports will not be believed.